GALANTI RICHARD A 4

4 · Medline Inc. · Filed Jun 15, 2026

AI-generated summary of this filing

Updated Jun 15, 2026

Medline (MDLN) Director Richard Galanti Receives RSU Awards

What Happened

Richard Galanti, a director of Medline Inc. (MDLN), received equity awards in the form of restricted stock units (RSUs) reported on a Form 4 filed June 15, 2026. The filing records two acquisitions: 11,005 RSUs dated 2025-12-16 (reclassified from prior interests; no per-share price reported) and 5,387 RSUs dated 2026-06-11 granted at $0.00 (no cash paid). Combined, these awards equal 16,392 RSUs. These are awards (not open-market purchases or sales) and represent equity compensation rather than a buying/selling decision.

Key Details

Transaction dates and amounts:
- 2025-12-16: 11,005 RSUs acquired (per-share price listed as N/A); footnote indicates these were reclassified interests from Medline Holdings, LP prior to the IPO and were previously reported on a Form 3 filed 12/17/2025. Vesting: March 30, 2027 (see F1).
- 2026-06-11: 5,387 RSUs granted at $0.00 (no cash consideration). Vesting: earlier of the first anniversary of grant or the next annual meeting of stockholders (see F2).
Total RSUs awarded in this filing: 16,392.
Shares owned after the transactions: not specified in the Form 4 disclosure provided.
Notable footnotes: F1 explains the 12/16/2025 reclassification tied to pre-IPO interests and previously reported on Form 3; F2 describes the one-year/next-meeting vesting condition for the June 11 grant.
Filing timing: Form 4 was filed 2026-06-15 and reports the above-dated awards; the Dec 16, 2025 reclassification was previously disclosed on a Form 3 (12/17/2025).

Context

RSU awards are a common form of equity compensation for executives/directors and do not by themselves indicate buying or selling sentiment. They typically vest over time (as noted) and align the recipient’s incentives with shareholders. No options were exercised and no shares were sold in this filing.

Form 4

Period: 2025-12-16

Director

Transactions

Footnotes (2)

[F1]These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027.
[F2]Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.

Signature

/s/ Nicole Fritz, Attorney-in-Fact|2026-06-15

1 file